Accelerate Diagnostics, Inc. (LON: 0H8E)
London
· Delayed Price · Currency is GBP · Price in USD
1.090
-0.055 (-4.80%)
Jan 22, 2025, 5:03 PM BST
Accelerate Diagnostics Revenue
Accelerate Diagnostics had revenue of $2.98M USD in the quarter ending September 30, 2024, a decrease of -9.82%. This brings the company's revenue in the last twelve months to $11.91M, down -0.79% year-over-year. In the year 2023, Accelerate Diagnostics had annual revenue of $12.06M, down -5.43%.
Revenue (ttm)
$11.91M
Revenue Growth
-0.79%
P/S Ratio
n/a
Revenue / Employee
$88.87K
Employees
134
Market Cap
22.77M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.06M | -693.00K | -5.43% |
Dec 31, 2022 | 12.75M | 970.00K | 8.23% |
Dec 31, 2021 | 11.78M | 617.00K | 5.53% |
Dec 31, 2020 | 11.17M | 1.87M | 20.09% |
Dec 31, 2019 | 9.30M | 3.63M | 63.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Accelerate Diagnostics News
- 12 days ago - Accelerate Diagnostics reports preliminary FY 2024 revenue of $11.7 million - Seeking Alpha
- 12 days ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 15 days ago - GRIFFIN ASSET MANAGEMENT, INC. Reduces Holdings in Accelerate Diagnostics Inc - GuruFocus
- 2 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 4 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire
- 5 months ago - Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript - Seeking Alpha